Neurology News

During a September 2021 interview on The Tonight Show with Jimmy Fallon, comedian Hasan Minhaj referred to doctors of osteopathic medicine, or DOs, as “off-brand doctors” compared with their MD counterparts.

CHARLOTTE, N.C. — Study results indicate that better sleep efficiency in patients with fibromyalgia and insomnia may help improve their pain-related disability, according to a poster presented at the SLEEP meeting.

SAN DIEGO — A new neuropsychological test battery may be valuable for assessment of culturally diverse populations if barriers for testing are considered, according to an expert at the Alzheimer’s Association International Conference.

SAN DIEGO — Identifying regions vulnerable to beta-amyloid deposits in younger populations may help predict future accumulation, according to study results presented at the Alzheimer’s Association International Conference.

CHARLOTTE, N.C. — Data from a real-world study revealed that treatment with prescription digital therapeutic Somryst achieved reductions in symptoms of insomnia, anxiety and depression, per a late-breaking poster at the SLEEP meeting.

During a volatile market environment like we are in today or the steep market pullback at the onset of the pandemic in 2020, many investors, including physicians, feel a powerful drive to act in response.

A consortium led by Weill Cornell Medicine has been awarded a $14.7 million NIH grant for its research center, which focuses on emerging and existing technologies that provide support for older adults with cognitive impairments.

Patients with MS who took diroximel fumarate reported physical benefits, including slowed disease progression and decreased relapses, according to data presented at the Consortium of Multiple Sclerosis Centers annual meeting.

Marinus Pharmaceuticals Inc. announced the Unites States commercial launch of Ztalmy oral suspension for the treatment of seizures associated with CDKL5 deficiency disorder in patients aged 2 years and older.

Quanterix Corp. announced the validation of a laboratory-developed test to quantitatively measure phospho-Tau 181 concentration in plasma to aid in the diagnosis of Alzheimer’s disease.